Astrazeneca Plc

142.00 (1.22%)
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  142.00 1.22% 11,784.00 11,778.00 11,780.00 11,830.00 11,636.00 11,690.00 1,433,452 16:35:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceutical Preparations - - 212.2 54.9 182,634.00

AstraZeneca's Airsupra Approved by FDA to Treat Asthma

11/01/2023 1:43pm

Dow Jones News

Astrazeneca (LSE:AZN)
Historical Stock Chart

From Nov 2022 to May 2023

Click Here for more Astrazeneca Charts.

By Anthony O. Goriainoff


AstraZeneca PLC said Wednesday that the U.S. Food and Drug Administration approved its Airsupra product for the treatment of asthma.

The London-listed pharmaceutical company said the approval was based on results from the Mandala and Denali Phase 3 trials.

The company said Airsupra has been approved for "the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older."

The company said Airsupra's safety and tolerability in both trials were consistent with the known profiles of the components, and that the most common adverse events included headache, oral candidiasis, cough and dysphonia.

Shares at 1308 GMT were down 40 pence, or 0.3%, at 11,762 pence.


Write to Anthony O. Goriainoff at


(END) Dow Jones Newswires

January 11, 2023 08:28 ET (13:28 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: gb D: 20230529 21:44:49